from Reuters: Business News https://ift.tt/2CDx2m3
Monday, September 10, 2018
Monday, September 10, 2018
MZ Digital Marketing Agency
BUSINESS NEWS
No comments
Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible for medicine use within the state health service not to approve its drug Ocrevus for treating a highly disabling form of multiple sclerosis (MS).

from Reuters: Business News https://ift.tt/2CDx2m3
from Reuters: Business News https://ift.tt/2CDx2m3
Related Posts:
LATEST BUSINESS NEWS"Taking scary decisions is critical", says James Dawson who junked his existing teas to start again. from BBC News - Business https://ift.tt/2FIwCci … Read More
LATEST BUSINESS NEWSLyft is the first ride-sharing company to go public but Uber is expected to follow soon. from BBC News - Business https://ift.tt/2JPH7jF … Read More
LATEST BUSINESS NEWSRecently retired Pat and John say their motor home travel plans are on hold because of Brexit. from BBC News - Business https://ift.tt/2YyAcP6 … Read More
LATEST BUSINESS NEWSSports Direct boss Mike Ashley is considering a £61m bid for Debenhams, but can he can save it? from BBC News - Business https://ift.tt/2CIiCPp … Read More
LATEST BUSINESS NEWSYianni Charalambous transforms cars for the rich and famous people searching for that extra shine. from BBC News - Business https://ift.tt/2HLg0Et … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment